ALNY | 5.16% | 324.69 | +0.58% | 7,221 | |
CRSP | 5.07% | 55.09 | -0.09% | 45,334 | |
ILMN | 4.98% | 97.93 | +1.00% | 22,914 | |
Qiagen NV | - | 4.35% | - | - | 41,285 |
MRNA | 4.32% | 32.20 | +0.44% | 65,832 | |
GH | 4.16% | 47.28 | -1.11% | 38,282 | |
NTRA | 4.12% | 143.38 | -3.38% | 11,761 | |
TECH | 4.01% | 53.29 | +2.90% | 34,832 | |
RARE | 4.00% | 27.41 | +0.37% | 46,829 | |
LEGN | 3.96% | 42.13 | +5.99% | 50,939 |
Global X Funds - Global X Genomics & Biotechnology ETF is an exchange traded fund launched and managed by Global X Management Company LLC. It invests in the public equity markets of global region. It invests in stocks of companies operating across genomic science and biotechnology, healthcare, pharmaceuticals, biotechnology and life sciences sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the Solactive Genomics Index, by using full replication technique. Global X Funds - Global X Genomics & Biotechnology ETF was formed on April 5, 2019 and is domiciled in the United States.